MREO vs PCAR · $48.7M cap vs P/E 25, rev $33.66B
Mereo BioPharma Group PLC ADR (MREO) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
MREO currently screens at market cap $48.7M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the MREO and PCAR stock pages for the full models.
Not investment advice.